Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 19 Dec 2023  |  North America  |  Market Research

    Growth Opportunities in US Digital Health Solutions as an Enabler for Value-based Care

    Robust Investments and Disruptive Technological Innovation Transforming Care Delivery

    According to the Centers for Medicare and Medicaid Services (CMS), value-based care (VBC) programs reward healthcare providers with incentive payments for the quality of care they provide Medicare patients. These programs are part of its larger CMS quality strategy to reform healthcare delivery and payment. Value-based programs support 3 aims: b...

    $2,450.00
  2. 10 May 2023  |  Global  |  Market Research

    Growth Opportunities in the Biologics Contract Development and Manufacturing Organization Sector

    Value Chain Expansion to Support Next generation Biologics Drives Future Growth Potential

    This research service provides an overview of the global biologics contract development and manufacturing organization (bio-CDMO) market and a 6-year market revenue forecast (2023 to 2028). The geographic scope covers three key regions, namely North America (NA); Europe; and Asia-Pacific (APAC). The report offers a detailed segment analysis of...

    $4,950.00
  3. 03 Feb 2023  |  North America  |  Market Research

    Global Pharmaceutical Continuous Manufacturing Market, Growth Opportunities

    Regulatory Acceptance Propelling Continuous Manufacturing Investments through Partnerships and In-house Expansions

    Continuous manufacturing (CM) is a method for manufacturing end-to-end pharmaceutical products on a single, uninterrupted production line. While batch manufacturing requires transporting, testing, and refeeding materials from one process to the next, continuous processes execute all testing, feeding, and processing inline at a single manufacturing ...

    $4,950.00
  4. 13 Jan 2023  |  Global  |  Market Research

    Global Life Science Instrumentation and Research Tool Growth Opportunities

    Automation and Robotization to Ensure Industrywide Streamlining and Increase Future Growth Potential

    New technological advances in life science instrumentation and research tools include the enhancement of next-generation sequencing (NGS) technology, digital PCR, and a wide range of informatics, robotics, and automated solutions. These improve workflow, facilitate and automate tasks, and make better use of workspaces in every area of industry. ...

    $4,950.00
  5. 23 Dec 2020  |  North America  |  Market Research

    I-O Therapy Combinations Spurring Growth of the Global Immuno-oncology Market

    Upcoming Product Launches in Adoptive Cell Therapy Segment Hold Future Growth Potential

    This study explores the global immuno-oncology (I-O) markets evolution from 2020 to 2025. An extensive analysis is provided on the growth opportunities envisioned by Frost & Sullivan to help stakeholders leverage their momentum and disrupt the market by offering best-in-class solutions. The study considers oncology agents for which the immune syst...

    $4,950.00
  6. 11 Dec 2020  |  North America  |  Market Research

    COVID-19 Pandemic Catalyzes the Transformation of the In-vitro Diagnostics Industry

    Future Growth Potential is Enriched by Alternate Testing Sites in the Point-of-Care Testing Segment

    This research service provides critical insights into the impact of COVID-19 on the global in-vitro diagnostics (IVD) industry, highlighting the growth opportunities, market revenue, and technology trends that influence its growth. Its three major segments identify the strategic imperatives of the IVD industry, the impact of COVID-19 on the IVD gro...

    $2,450.00
  7. 11 Dec 2020  |  North America  |  Market Research

    Demand for High-Volume Testing Driving the Growth of the US Clinical Chemistry and Immunoassay In Vitro Diagnostics Market, 2020

    Serology Assays for COVID-19 Diagnosis Present an Immediate Growth Opportunity

    The Transformational Health team at Frost & Sullivan provides critical insights into the US clinical chemistry and immunoassay industry, highlighting the recent activities, key growth opportunities, and trends that are shaping the industry. The already dynamic in vitro diagnostics landscape in the United States was affected even more by the recen...

    $2,450.00
  8. 23 Oct 2020  |  Global  |  Market Research

    Supply Chain Optimization and Decentralized Manufacturing to Expand the Contract Cell and Gene Therapy Manufacturing Market, 2020–2026

    Automation Deployed to Contain Cost of Goods Sold and Vector Manufacturing Standardization will Create New Growth Opportunities

    The cell and gene therapy segment is one of the fastest growing segments in the biopharmaceutical space. While the science behind the therapy has grown by leaps and bounds on the back of decades worth of research, manufacturing has unfortunately lagged behind. To fully harness the curative potential of these therapies and ensure greater reach and a...

    $4,950.00
  9. 23 Oct 2020  |  North America  |  Market Research

    Access to New Therapy Areas to Drive Major Growth in the Global Biosimilars Market, 2020–2026

    Outsourced Manufacturing of the Complex Third Wave of Biosimilars to Spark New Growth Opportunities

    In this research service, the Transformational Health team at Frost & Sullivan provides critical insights into the global biosimilar industry, highlighting the key growth opportunities, market revenue forecasts, and trends that will influence the industry with the emergence of the third wave of biosimilars. The global third-wave biosimilars market ...

    $4,950.00
  10. 14 Sep 2020  |  North America  |  Market Research

    Smartphone-based Solutions Spur the Global Infectious Disease Point-of-Care Testing Market, Forecast to 2024

    COVID-19 and STDs among Millennials Speed Development of Miniaturized POCT Devices and Alternate Care Sites to Enable Transformational Growth

    The COVID-19 pandemic prompted a transformation in the infectious disease point-of-care testing (POCT) market. The shift towards miniaturized POCT devices will lead to the emergence of cost-effective integrated lab-on-a-chip devices based on microfluidic technologies and smartphone-based solutions enabling multiplexed detection of infectious pathog...

    $4,950.00